PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Department of Internal Medicine Saiseikai Matsuyama Hospital

Hypothesis

Can PuraStat be effective for achieving hemostasis in Mallory-Weiss syndrome when other methods fail?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods are insufficient.

Supporting Evidence

  • PuraStat has been used successfully in other types of gastrointestinal bleeding.
  • The patient achieved hemostasis after PuraStat was applied following failed clipping.

Takeaway

PuraStat is a special gel that helps stop bleeding in the stomach when other treatments don't work.

Methodology

A case report of a 67-year-old man treated with PuraStat after traditional methods failed.

Limitations

This is a single case report, so broader conclusions cannot be drawn.

Participant Demographics

67-year-old man with a history of coronary artery bypass grafting and on antithrombotic medication.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication